BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 36627707)

  • 1. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
    Tien FM; Lu HH; Lin SY; Tsai HC
    J Biomed Sci; 2023 Jan; 30(1):3. PubMed ID: 36627707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications.
    Yin J; Gu T; Chaudhry N; Davidson NE; Huang Y
    Front Immunol; 2023; 14():1325615. PubMed ID: 38268926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
    Dai E; Zhu Z; Wahed S; Qu Z; Storkus WJ; Guo ZS
    Mol Cancer; 2021 Dec; 20(1):171. PubMed ID: 34930302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications.
    Zhu D; Zeng S; Su C; Li J; Xuan Y; Lin Y; Xu E; Fan Q
    Clin Epigenetics; 2024 Feb; 16(1):24. PubMed ID: 38331927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
    Cao J; Yan Q
    Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
    Pan X; Zheng L
    Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer.
    Luo H; Shan J; Zhang H; Song G; Li Q; Xu CX
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):960-970. PubMed ID: 35189321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy.
    Xiao C; Fan T; Zheng Y; Tian H; Deng Z; Liu J; Li C; He J
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
    Niu Y; Chen J; Qiao Y
    Front Immunol; 2022; 13():836223. PubMed ID: 35140725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
    Cheng B; Yu Q; Wang W
    J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
    Maes K; Mondino A; Lasarte JJ; Agirre X; Vanderkerken K; Prosper F; Breckpot K
    Front Immunol; 2021; 12():652160. PubMed ID: 33859645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of epigenetic therapeutics in immuno-oncology.
    Topper MJ; Vaz M; Marrone KA; Brahmer JR; Baylin SB
    Nat Rev Clin Oncol; 2020 Feb; 17(2):75-90. PubMed ID: 31548600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.
    Cruickshank B; Giacomantonio M; Marcato P; McFarland S; Pol J; Gujar S
    Front Immunol; 2018; 9():654. PubMed ID: 29666625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
    Zhang J; Huang L; Ge G; Hu K
    Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic control of the tumor microenvironment.
    Marks DL; Olson RL; Fernandez-Zapico ME
    Epigenomics; 2016 Dec; 8(12):1671-1687. PubMed ID: 27700179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.
    Liu M; Zhou J; Chen Z; Cheng AS
    J Pathol; 2017 Jan; 241(1):10-24. PubMed ID: 27770445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning Cold into Hot: Firing up the Tumor Microenvironment.
    Duan Q; Zhang H; Zheng J; Zhang L
    Trends Cancer; 2020 Jul; 6(7):605-618. PubMed ID: 32610070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.